(Q37125977)

18 August 2017

Screening for Down's syndrome: effects, safety, and cost effectiveness of first and second trimester strategies (English)

1 reference

cost-effectiveness analysis

18 August 2017

1 reference

R E Gilbert

1

1 reference

18 August 2017

C Augood

2

1 reference

18 August 2017

R Gupta

3

1 reference

18 August 2017

A E Ades

4

1 reference

18 August 2017

S Logan

5

1 reference

18 August 2017

M Sculpher

6

1 reference

18 August 2017

J H van Der Meulen

7

1 reference

18 August 2017

language of work or name

English

0 references

publication date

1 August 2001

1 reference

18 August 2017

1 reference

18 August 2017

323

1 reference

18 August 2017

7310

1 reference

18 August 2017

423-425

1 reference

Second trimester prenatal screening for Down's syndrome using alpha-fetoprotein and free beta hCG: a seven year review.

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=37550

Effect of study design on the association between nuchal translucency measurement and Down syndrome

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=37550

Factors affecting uptake of antenatal HIV testing in London: results of a multicentre study.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=37550

Marginal costs and benefits

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=37550

Maternal serum screening for Down's syndrome in early pregnancy

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=37550

Preferences of women facing a prenatal diagnostic choice: long-term outcomes matter most

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=37550

Antenatal screening for Down's syndrome.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=37550

Justifying prenatal screening and genetic amniocentesis programs by cost-effectiveness analyses: a re-evaluation

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=37550

First trimester fetal nuchal translucency: problems with screening the general population. 2.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=37550

Maternal serum screening for Down's syndrome: the effect of routine ultrasound scan determination of gestational age and adjustment for maternal weight

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=37550

Combining ultrasound and biochemistry in first-trimester screening for Down's syndrome.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=37550

The imprecision in rates of Down syndrome by 1-year maternal age intervals: a critical analysis of rates used in biochemical screening

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=37550

Use of the disutility ratio in prenatal screening for Down's syndrome

3 September 2018

1 reference

12 December 2020

Integrated screening for Down's syndrome based on tests performed during the first and second trimesters

1 reference

12 December 2020

Economic evaluation of prenatal screening for Down syndrome in the U.S.A.

1 reference

12 December 2020

UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10–14 weeks of gestation

1 reference

12 December 2020

Cost-benefit analysis of prenatal diagnosis for Down syndrome using the British or the American approach

1 reference

12 December 2020

Intra- and interoperator repeatability of the nuchal translucency measurement

1 reference

12 December 2020

Women's knowledge of and attitudes to first and second trimester screening for Down's syndrome

1 reference

12 December 2020

The impact of maternal serum screening on the birth prevalence of Down's syndrome and the use of amniocentesis and chorionic villus sampling in South Australia

1 reference

12 December 2020

An economic appraisal of alternative pre-natal screening programmes for Down's syndrome

1 reference

12 December 2020

Preferences of pregnant women for amniocentesis or chorionic villus sampling for prenatal testing: comparison of patients' choices and those of a decision-analytic model

1 reference

12 December 2020

Down's syndrome screening in the UK in 1998

1 reference

12 December 2020

Selective miscarriage of Down's syndrome fetuses in women aged 35 years and older

1 reference

12 December 2020

Prenatal screening for Down's syndrome using inhibin-A as a serum marker

1 reference

12 December 2020

Abnormalities of the heart and great arteries in chromosomally normal fetuses with increased nuchal translucency thickness at 11-13 weeks of gestation

1 reference

12 December 2020

Screening for Down's syndrome: changes in marker levels and detection rates between first and second trimesters

1 reference

12 December 2020

Screening of maternal serum for fetal Down's syndrome in the first trimester

1 reference

12 December 2020

Correct estimation of parameters for ultrasound nuchal translucency screening

1 reference

12 December 2020

Identifiers

DOI

10.1136/BMJ.323.7310.423

1 reference

18 August 2017

1 reference

18 August 2017

1 reference